All-trans retinoic acid potentiates the antibody response in mice to a lipopeptide antigen adjuvanted with liposomal lipid A

Immunology and Cell Biology

Volumn 87, Issue 8, 2009, Pages 630-633

  Watson, Douglas S ^a   Huang, Zhaohua ^a   Szoka Jr , Francis C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gp41; Lipid A; Liposomes; Membrane proximal region; Retinoic acid

Indexed keywords

ASPARAGINYLGLUTAMYLGLUTAMINYLGLUTAMYLLEUCYLLEUCYL GLUTAMYLLEUCYLASPARTYLLYSYLTRYPTOPHYLALANYLSERYLLEUCYLASPARAGINYL GLYCYLGLYCYLLYSINE; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G ANTIBODY; ISOTRETINOIN; LIPOPEPTIDE; LIPOSOME; PEPTIDE ANTIBODY; PHOSPHORYL LIPID A; RETINOIC ACID; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENTIATION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; LIPID VESICLE; MOUSE; NONHUMAN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; DRUG SYNERGISM; FEMALE; HIV ENVELOPE PROTEIN GP41; HIV-1; LIPID A; LIPOPEPTIDES; LIPOSOMES; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; TRETINOIN;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; RODENTIA;

EID: 70450228599     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.48     Document Type: Article

References (22)

1. Ertesvag A, Naderi S, Blomhof H. Regulation of B cell proliferation and differentation by retinoic acid. Semin Immunol 2009; 21: 36-41.
2. Pasatiempo A, Kinoshita M, Taylor C, Ross A. Antibody production in vitamin A-depleted rats is impaired after immunization with bacterial polysaccharide or protein antigens. FASEB J 1990; 4: 2518-2527.
3. Ross A, Chen Q, Ma Y. Augmentation of antibody responses by retinoic acid and costimulatory molecules. Semin Immunol 2009; 21: 42-50.
4. Manicassamy S, Pulendran B. Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages. Semin Immunol 2009; 21: 22-27.
5. DeCicco K, Youngdahl J, Ross A. All-trans-retinoic acid and polyriboinosinic:polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity. Immunology 2001; 104: 341-348.
6. Ma Y, Chen Q, Ross A. Retinoic acid and polyriboinosinic: polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1 / type 2 cytokines and lymphocyte populations. J Immunol 2005; 174: 7961-7969.
7. Montero M, van Houten N, Wang X, Scott J. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: Dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev 2008; 72: 54-85.
8. Ofek G, Tang M, Sambor A, Katinger H, Mascola JR, Wyatt R et al. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 2004; 78: 10724-10737.
9. Haynes BF, Alam SM. HIV-1 hides an Achilles' heel in virion lipids. Immunity 2008; 28: 10-12.
10. Alving C. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 1993; 187: 430-446.
11. Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci 2000; 97: 2163-2167.
12. Watson D, Szoka FC. Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41. Vaccine 2009; 27: 4672-4683.
13. Dijkstra J, Ryan J, Szoka Jr F. A procedure for the efficient incorporation of wild-type lipopolysaccharide into liposomes for use in immunological studies. J Immunol Methods 1988; 114: 197-205.
14. Richards R, Hayre M, Hockmeyer W, Alving C. Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen. Infect Immun 1988; 56: 682-686.
15. Richards R, Alving C, Wasseff N. Liposomal subunit vaccines: Fffects of lipid A and aluminum hydroxide on immunogenicity. J Pharm Sci 1996; 85: 1286-1289.
16. Tokuyama Y, Tokuyama H. Retinoids as Ig isotype-switch modulators. The role of retinoids in directing isotype switching to IgA and IgG1 (IgE) in association with IL-4 and IL-5. Cell Immunol 1996; 170: 230-234.
17. Symons A, Beinke S, Ley S. MAP kinase kinase kinases and innate immunity. Trends Immunol 2006; 27: 40-48.
18. Engedal N, Gjevik T, Blomhoff R, Blomhoff H. All-trans retinoic acid stimulates IL-2- mediated proliferation of human T lymphocytes: Farly induction of Cyclin D3. J Immunol 2006; 177: 2851-2861.
19. Blaner W. Cellular metabolism and actions of 13-cis retinoic acid. J Am Acad Dermatol 2001; 45: S129-S135.
20. Repa J, Hanson K, Clagett-Dame M. All-trans-retinol is a ligand for the retinoic acid receptors. Proc Natl Acad Sci 1993; 90: 7293-7297.
21. Huang Z, Szoka F. Sterol-modified phospholipids: Cholesterol and phospholipid chimeras with improved biomembrane properties. J Am Chem Soc 2008; 130: 15702-15712.
22. Fujii G, Ernst W, Adler-Moore J. The VesiVax system: A method for rapid vaccine development. Front Biosci 2008; 13: 1968-1980.